3. Giant Cell Tumor of Bone
There are numerous primary tumors of bone with giant cell or
or macrophage activity seen within the tumor under the microscope.
These include the aneurysmal bone cyst, chondroblastoma, solitary
bone cyst, osteoid osteoma, osteoblastoma, fibrous dysplasia and
osteogenic sarcoma, hemorrhagic type. Some pathologists classify
these tumors as variants of the true giant cell tumor making it almost
a diagnosis of exclusion if none of the above diagnoses can be
established histologically. The clinical entity known as the benign
giant cell tumor of bone is seen typically in young adult females
between the ages of 20 and 40 years. It is less common in males. The
lesion is usually found in the ends of long bones, most commonly
about the knee joint where 50% of the lesions will be seen. The next
most common locations are the sacrum and distal radius. The other
epiphyseal tumor seen in children is the chondroblastoma that also
has giant cell activity in the tumor. Even the so-called brown tumor
of hyperparathyroidism has excessive macrophage activity but is a
4. pseudotumor induced by parathormone producing lesions such as
parathyroid adenomas and secondary hyperparathyroidism seen in
renal failure disease.
Currently most experts feel that the giant cell tumor is a low-grade,
benign mesenchymal tumor with a fibro-osteoblastic stem cell with a
molecular genetic defect similar to the stem cell of the osteosarcoma
but with a greater degree of molecular genetic stability. The giant cell
seen in this tumor is simply an immune response by the host in an
attempt to remove the neoplastic fibro-osseous tissue. Giant cell
tumors account for between 5-10 per cent of all benign tumors of the
skeletal system. They are usually associated with pain in the adjacent
joint involved, such as the knee joint, which may cause an effusion.
radiographically, the lesion is very characteristic because of its purely
lytic nature that can be very geographic in nature, located in the
epiphyseal-metaphyseal location of a long bone, frequently coming in
direct contact with the subchondral bone of the adjacent joint. In more
aggressive cases, the lesion can break through the adjacent metaphyseal
5. cortex and gain access to the subperiosteal space and take on the
appearance of a more malignant process, such as a hemorrhagic
osteosarcoma.
Even though this condition is considered benign with a very low
mitotic index seen in the stromal cells, one or two per cent of the
tumors can metastasize to the lung as a benign process. There is an
excellent prognosis for cure with simple surgical resection in 80% of
the cases. Treatment usually consists of an aggressive curettement
of the tumor followed by a packing of the defect with either bone
graft, in smaller lesions, or more typically with bone cement in
larger lesions which gives a better chance of a permanent cure with
about a 5 to 10% recurrence rate with the cementation technique. In
more aggressive lesions located in the sacrum or anterior portion
of the spinal column, surgical resection is very difficult because of
the adjacent nerve roots or spinal cord, in which case occasionally
local radiation is used. However, in about 5% of cases, this can
convert the tumor into a high-grade tumor sarcoma at a much later
6. date. The tumor also has the potential for spontaneous conversion
to a high grade tumor, such as an osteosarcoma or a malignant
fibrous histiocytoma, in about 1% of cases.
Giant cell tumors that have a local recurrence have a greater
potential for pulmonary metastasis, running as high as 6% and, for
this reason, chest x-rays should be obtained periodically for a
period of approximately three years after the primary treatment of
the tumor.
120. 6 mos following a traumatic
fracture of tibia and again
normal knee function
121. Case #1046
37 year female with prior
cementation procedure for
GCT followed later with
a recent removal of cement
and replacement with present
cancellous allograft
122. 1 year later with collapse of
patellofemoral joint and loss
of active knee extension
186. Case #1052
69 year male with prior
history of GCT distal
femur treated with curettement
and bone graft 35 years ago.
Now has a path fracture thru
OGS at the same site
old bone graft
223. Later she developed a
recurrence in the tibia
which led to an AK amp
and then developed the
path fracture in femoral
stump seen here thru yet
another multifocal GCT
Later on she developed
benign pulmonary mets
and died 6 mos later while
on chemotherapy
315. Case #1075
31 year male with
prior history of GCT
prox ulna treated 5
years ago with bone
graft and radiation
Now we see x-ray
evidence of OGS
2nd to the radiation